Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face (SunDamage)
Actinic Keratosis
About this trial
This is an interventional treatment trial for Actinic Keratosis
Eligibility Criteria
Inclusion Criteria: Informed consent Diagnosed with sun-damaged skin on the face and AK in the treatment area Willing and able to comply with all study procedures Use of medically acceptable contraception in males or females of child-bearing potential 51 -100 years of age Negative pregnancy test at baseline in females of childbearing potential Exclusion Criteria: Allergy or intolerance towards the active ingredient or any of the constituents of the IMP Any contraindication for the IMP, according to the most recent version of the SmPC Open lesions of any kind on the face Concomitant cutaneous malignancy in treatment area, including but not restricted to squamous skin cancer Immune deficiency Participation in another clinical trial during the last six months Pregnancy or lactation
Sites / Locations
- Medizinische Universität GrazRecruiting
Arms of the Study
Arm 1
Experimental
Treatment